Sarepta Therapeutics CEO Doug Ingram Plans Departure Following A Significant Year Of Regulatory Struggles
Sarepta Therapeutics announced today that Chief Executive Officer Doug Ingram will step down from his leadership role, marking the end of a
by 
Josh Weiner
Josh Weiner